Can You Still Get Mounjaro for Weight Loss? Exploring Your Options

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro is a prescription medication containing tirzepatide, a dual GLP-1 and GIP receptor agonist approved by the FDA for weight management in adults with obesity or overweight conditions. PlexusDx compounds tirzepatide from licensed 503A pharmacies, offering the same active ingredient at a predictable price point at $289/mo month-to-month, or from $249/mo on the 6-month plan.

What Happened to Mounjaro Availability for Weight Loss?

Mounjaro (brand tirzepatide) remains FDA-approved for type 2 diabetes and is still prescribed by healthcare providers across the United States; Zepbound is the weight-management brand. The medication continues to be dispensed through traditional pharmacies when covered by insurance or paid out-of-pocket at brand prices. High demand, intermittent supply shortages, and insurance coverage restrictions have led many patients to explore alternative sources, including compounded versions of the same active ingredient.

Compounded tirzepatide is legally produced in licensed 503A compounding pharmacies under FDA oversight. These facilities prepare customized medications using the same tirzepatide pharmaceutical-grade raw material as brand manufacturers. PlexusDx partners exclusively with licensed 503A compounding pharmacies to deliver consistent, quality-assured tirzepatide injections without the cost barriers associated with brand Mounjaro.

Compounded Tirzepatide vs. Brand Mounjaro: Key Differences

Brand Mounjaro and compounded tirzepatide contain identical active pharmaceutical ingredients but differ in packaging, manufacturer, and pricing. Brand Mounjaro typically costs between $900 and $1,500 per month without insurance, while PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan). Both are administered as weekly subcutaneous injections and work through the same biological mechanism: activating GLP-1 and GIP receptors in the brain and pancreas to reduce hunger and improve glucose control.

PlexusDx compounded tirzepatide comes in vials rather than pre-filled pens, and dosing is customized by your healthcare provider based on your clinical response. The active drug itself—tirzepatide—functions identically to brand Mounjaro. Your dose may need to go up. Your price won't. PlexusDx maintains flat-rate pricing regardless of dosage adjustments, removing the financial uncertainty many patients face with traditional pharmacy models.

Why Choose PlexusDx Tirzepatide Over Other Options?

PlexusDx tirzepatide injection offers three key advantages for weight loss patients: transparent, affordable pricing; accessibility without insurance; and personalized dosing protocols. The medication is produced in licensed 503A compounding pharmacies, meaning each batch undergoes quality control and meets pharmaceutical standards. PlexusDx serves all 50 states, accepts HSA and FSA funds, and charges no membership fees—making compounded tirzepatide available to patients who face insurance denials, high deductibles, or geographic access barriers.

Personalization is central to PlexusDx's approach. The optional Precision Peptide Genetic Test (add-on after first month, $99) maps 14 peptide pathways and 49 peptide variants to identify your genetic response to tirzepatide and other GLP-1 and GIP-based therapies. Key genetic variants like GIPR rs1800437 and GLP1R rs6923761 influence how effectively your body responds to dual-receptor therapy, allowing your PlexusDx provider to optimize your treatment plan with precision.

How to Get Started With PlexusDx Tirzepatide

Beginning PlexusDx compounded tirzepatide involves a straightforward enrollment process: complete an online medical intake, connect with a licensed PlexusDx healthcare provider, and receive a customized tirzepatide prescription. Your provider assesses your medical history, weight loss goals, and current health status to determine the appropriate starting dose and titration schedule. Once prescribed, your tirzepatide is compounded at a licensed 503A pharmacy and shipped directly to your home with injection supplies and detailed instructions.

Your dose typically begins low and increases gradually over 4-12 weeks to reach your therapeutic level—a process called titration. PlexusDx pricing remains flat at $289 per month regardless of dose adjustments, ensuring no surprise cost increases as your prescription strength changes. You maintain ongoing provider communication to monitor your weight loss progress, hunger suppression, and any side effects, with adjustments made as needed to optimize your results.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded tirzepatide the same as Mounjaro?

Compounded tirzepatide contains the identical active pharmaceutical ingredient as brand Mounjaro and works through the same biological mechanism. The difference is manufacturing source, packaging, and pricing. PlexusDx compounded tirzepatide is produced in licensed 503A pharmacies and costs significantly less than brand Mounjaro while delivering the same therapeutic effect.

What clinical evidence supports tirzepatide for weight loss?

Tirzepatide was approved by the FDA for weight management based on the SURMOUNT trials, which demonstrated average weight loss of 20-22% over 72 weeks in patients with obesity. Dual GLP-1 and GIP receptor activation produces greater appetite suppression and metabolic improvements than GLP-1 monotherapy alone, making tirzepatide highly effective for sustained weight reduction.

How much does PlexusDx compounded tirzepatide cost?

PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) and remains that price regardless of your dose level. No insurance is required, and HSA and FSA funds are accepted. Your dose may need to go up. Your price won't—PlexusDx's commitment to transparent, flat-rate pricing removes financial uncertainty from your weight loss journey.

Are there side effects with compounded tirzepatide?

Compounded tirzepatide produces the same side effect profile as brand Mounjaro, most commonly nausea, vomiting, and constipation during the first few weeks. These effects typically diminish as your body adjusts. Serious side effects are rare but may include pancreatitis or thyroid concerns; your PlexusDx provider monitors your health throughout treatment and adjusts your plan if needed.

What is the PlexusDx Precision Peptide Genetic Test?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.